14 terminated. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Terminated 14 |
Follow Low Back Pain: new trials by email Literature Review of Low Back Pain trials Research Report on Low Back Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA), Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA) - Sacroiliac Joint Complex, Low Back Pain | Phase 4 | Terminated | University of Utah | 20 | 2022-08-15 | 2026-06-26 |
| Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily, 380 mg/300 mg comprimidos metocarbamol/paracetamol - 6 times daily - Low Back Pain | Phase 4 | Terminated | Aziende Chimiche Riunite Angelini Francesco S.p.A | 172 | 2021-10-07 | 2025-01-31 |
| Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain Cannabidiol - Back Pain, Low | Phase 4 | Terminated | Massachusetts General Hospital | 7 | 2019-11-13 | 2022-05-04 |
| Intradiscal Platelet Rich Plasma Low back intradiscal injection of platelet rich plasma (PRP) - Discogenic Pain, Low Back Pain | Phase 4 | Terminated | University of Utah | 3 | 2019-02-14 | 2023-12-11 |
| Threshold Response of Lumbar Selective Nerve Root Block in Predicting Good Outcome Following Lumbar Foraminotomy Selective Nerve Root Block - Back Pain, Radiculopathy Lumbar | Phase 4 | Terminated | The Cleveland Clinic | 11 | 2018-08-23 | 2023-07-21 |
| A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief Exparel, Bupivacaine - Low Back Pain, Lumbosacral Radiculopathy | Phase 4 | Terminated | Virtua Health, Inc. | 19 | 2016-12-01 | 2021-01-06 |
| Postoperative Opioid Use and Pain Scores in Patients Undergoing Transforaminal Lumbar Interbody Fusion Acetaminophen, Placebo comparator - Low Back Pain | Phase 4 | Terminated | Texas Tech University Health Sciences Center | 21 | 2013-10-01 | 2020-05-06 |
| Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain Botulinum Toxin A, Placebo - Low Back Pain | Phase 4 | Terminated | United States Department of Defense | 2008-06-01 | 2009-03-05 | |
| Trial of Disc Biacuplasty to Treat Chronic Discogenic Low Back Pain Disc biacuplasty, Sham biacuplasty - Low Back Pain | Phase 4 | Terminated | Baylis Medical Company | 40 | 2008-04-01 | 2010-06-07 |
| Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy donepezil, duloxetine, donepezil 2.5 mg and duloxetine 30mg - Diabetic Neuropathic Pain, Chronic Low Back Pain | Phase 4 | Terminated | Wake Forest University | 22 | 2008-02-01 | 2018-09-11 |
| Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain Botulinum toxin B, Placebo - Low Back Pain | Phase 4 | Terminated | United States Department of Defense | 2008-02-01 | 2010-03-02 | |
| Percutaneous Neuromodulation Therapy (PNT) With Chronic Low Back Pain Patients Vertis Percutaneous Neuromodulation Therapy (PNT), Transcutaneous Electrical Nerve Stimulation (TENS) - Low Back Pain | Phase 4 | Terminated | RS Medical | 122 | 2005-12-01 | 2009-06-01 |
| A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain tramadol hydrochloride , acetaminophen - Back Pain, Low Back Pain | Phase 4 | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 22 | 2005-03-01 | 2011-06-10 |
| Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device Lumbar Interbody Fusion - Low Back Pain, Spondylolisthesis | Phase 4 | Terminated | Medtronic Spinal and Biologics | 102 | 2004-10-01 | 2018-02-13 |
Pain (3) · Back Pain (2) · Intervertebral Disc Displacement (2) · Spondylolisthesis (2) · Bronchiolitis Obliterans Syndrome (1) · Chronic Pain (1) · Constriction, Pathologic (1) · Diabetic Neuropathies (1) · Intervertebral Disc Degeneration (1) · Radiculopathy (1) · Spinal Stenosis (1) · Spondylolysis (1)
Neurologic Manifestations (14) · Pathological Conditions, Signs and Symptoms (14) · Signs and Symptoms (14) · Back Pain (12) · Pain (11) · Bone Diseases (2) · Hernia (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Pathological Conditions, Anatomical (2) · Peripheral Nervous System Diseases (2) · Spinal Diseases (2) · Spondylosis (2) · Bronchial Diseases (1)
Acetaminophen (1) · Botulinum Toxins, Type A (1) · Bupivacaine (1) · Cannabidiol (1) · Donepezil (1) · Duloxetine Hydrochloride (1) · Gabapentin (1) · Transcutaneous Electric Nerve Stimulation (1) · Ultracet (1) · rimabotulinumtoxinB (1)
United States Department of Defense (2) · University of Utah (2) · Aziende Chimiche Riunite Angelini Francesco S.p.A (1) · Baylis Medical Company (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Massachusetts General Hospital (1) · Medtronic Spinal and Biologics (1) · RS Medical (1) · Texas Tech University Health Sciences Center (1) · The Cleveland Clinic (1) · Virtua Health, Inc. (1) · Wake Forest University (1)
United States (10) · Canada (1) · Germany (1) · Italy (1) · Netherlands (1)
Jack W Tsao, MD (2) · James C Eisenach, MD (1) · Jason Felton, MD (1) · Jodi Gilman, PhD (1) · Michael Steinmetz, MD (1) · Robert Greenleaf, MD (1) · Robert S Burnham, MD (1) · William Carroll (1)
R01NS057594 (1)